(Q39471098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yu-Chieh Tsai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Defeng Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Caixia Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Shaoshun Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jing Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Min Yin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Shuyuan Yeh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Chawnshang Chang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

19 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

803-816

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Hormonal therapy for prostate cancer: current topics and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Combinatorial androgen receptor targeted therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Androgen receptor signaling and mutations in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

New developments in the chemistry and biology of the bioactive constituents of Tanshen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Cryptotanshinone but not tanshinone IIA inhibits angiogenesisin vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte injury in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Über die Einwirkung von Halogenphosphor auf Alkyl-formanilide. Eine neue Methode zur Darstellung sekundärer und tertiärer p -Alkylamino-benzaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

The Vilsmeier–Haack Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

From estrogen to androgen receptor: a new pathway for sex hormones in prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

New developments in the medical management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Androgen receptor and caveolin-1 in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21474

Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report)

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1351/PAC200880102195